Instrument/analyser IVDs

País: Australia

Idioma: inglés

Fuente: Department of Health (Therapeutic Goods Administration)

Disponible desde:

Martin Flynn PTY LTD

clase:

Class 1

Fabricado por:

DRG International Inc 841 Mountain Avenue, Springfield, NJ, 07081 United States Of America

Área terapéutica:

CT943 - Instrument/analyser IVDs

indicaciones terapéuticas:

HYB-5252 -GMDN 56718/62413 - The DRG:HYBRiD-XL? was developed for the use in Laboratories, Institutions and Doctors Practices. The DRG:HYBRID-XL? is capable of processing a broad variety of Clinical Chemistry and immunoassay. The DRG:HYBRiD-XL? is a random-access analyzer intended for professional use and must only be used by trained personnel working in compliance with the precautions for use set out in this manual and good laboratory practice (GLP).

Estado de Autorización:

A

Fecha de autorización:

2020-02-13